1 / 1

Amlodipine vs Valsartan Therapy and New-Onset Diabetes in High-Risk Hypertensives

This study compares the risk of new-onset diabetes in high-risk hypertensive patients treated with amlodipine-based therapy versus valsartan-based therapy. Findings from the American Hypertension Society's 20th Annual Scientific Session in 2005 support evidence-based treatment decisions.

cadman-buck
Télécharger la présentation

Amlodipine vs Valsartan Therapy and New-Onset Diabetes in High-Risk Hypertensives

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. VALUE: New-onset diabetes in an amlodipine-based vs valsartan-based therapy in high-risk hypertensives Jamerson KA. American Hypertension Society 20th Annual Scientific Session; May 14-18, 2005; San Francisco, CA.

More Related